MaaT Pharma SA (EPA:MAAT)
France · Delayed Price · Currency is EUR 3.190
+0.070 (2.24%)
Aug 21, 2026, 5:35 PM CET
MaaT Pharma Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 24.87 | 20.15 | 24.28 | 35.25 | 43.31 |
Short-Term Investments | - | - | - | 0.06 | - |
Cash & Short-Term Investments | 24.87 | 20.15 | 24.28 | 35.31 | 43.31 |
Cash Growth | 23.39% | -16.99% | -31.24% | -18.46% | 117.47% |
Accounts Receivable | 5.19 | 5.03 | 5.16 | 4.24 | 2.39 |
Other Receivables | 1.63 | 1.12 | 1.04 | 0.78 | 0.98 |
Receivables | 6.82 | 6.15 | 6.21 | 5.02 | 3.37 |
Inventory | 0.08 | 0.06 | 0.19 | 0.05 | 0.03 |
Prepaid Expenses | 1.05 | 1.07 | 1.13 | 1.58 | 0.43 |
Other Current Assets | 0.18 | 0.21 | 0.19 | 0.16 | 0.13 |
Total Current Assets | 32.99 | 27.64 | 31.99 | 42.12 | 47.27 |
Property, Plant & Equipment | 7.34 | 8.6 | 9.17 | 0.97 | 1.11 |
Long-Term Investments | - | - | - | - | 0.1 |
Other Intangible Assets | 1.84 | 1.77 | 1.34 | 1.2 | 0.81 |
Long-Term Deferred Charges | 2 | - | - | - | - |
Other Long-Term Assets | - | 0.2 | 0.2 | 0.3 | - |
Total Assets | 44.55 | 38.5 | 42.93 | 44.73 | 49.42 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 11.81 | 8.83 | 6.35 | 4.51 | 2.47 |
Accrued Expenses | 1.86 | 1.99 | 1.29 | 1.24 | 0.69 |
Current Portion of Long-Term Debt | 1.16 | 1.85 | 2.22 | 2.77 | 1.06 |
Current Portion of Leases | 1.34 | 1.28 | 1.23 | 0.21 | 0.19 |
Current Income Taxes Payable | 0.08 | 0.09 | 0.06 | 0.05 | 0.03 |
Current Unearned Revenue | 0.21 | - | - | - | - |
Other Current Liabilities | 0.52 | 0.53 | 0.37 | 0.44 | 0.25 |
Total Current Liabilities | 16.98 | 14.56 | 11.52 | 9.22 | 4.7 |
Long-Term Debt | 11.26 | 8.11 | 5.75 | 7.94 | 3.98 |
Long-Term Leases | 3.69 | 4.72 | 4.88 | 0.43 | 0.57 |
Pension & Post-Retirement Benefits | 0.21 | 0.17 | 0.17 | 0.1 | 0.12 |
Other Long-Term Liabilities | 10.62 | 0.6 | 0.15 | 0.23 | 0.19 |
Total Liabilities | 42.75 | 28.17 | 22.47 | 17.92 | 9.56 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1.89 | 1.4 | 1.16 | 0.99 | 0.99 |
Additional Paid-In Capital | 28.77 | 35.48 | 37.38 | 38.32 | 46.46 |
Retained Earnings | -28.65 | -26.3 | -17.86 | -12.37 | -7.6 |
Treasury Stock | -0.21 | -0.23 | -0.22 | -0.14 | - |
Shareholders' Equity | 1.8 | 10.34 | 20.47 | 26.81 | 39.86 |
Total Liabilities & Equity | 44.55 | 38.5 | 42.93 | 44.73 | 49.42 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 17.44 | 15.96 | 14.08 | 11.36 | 5.81 |
Net Cash (Debt) | 7.43 | 4.2 | 10.21 | 23.95 | 37.5 |
Net Cash Growth | 76.96% | -58.87% | -57.39% | -36.13% | 171.00% |
Net Cash Per Share | 0.47 | 0.32 | 0.90 | 2.42 | 15.45 |
Filing Date Shares Outstanding | 18.84 | 16.08 | 11.6 | 11.54 | 9.89 |
Total Common Shares Outstanding | 18.82 | 13.95 | 11.59 | 9.94 | 9.88 |
Working Capital | 16.02 | 13.08 | 20.47 | 32.91 | 42.57 |
Book Value Per Share | 0.10 | 0.74 | 1.77 | 2.70 | 4.03 |
Tangible Book Value | -0.05 | 8.57 | 19.12 | 25.61 | 39.05 |
Tangible Book Value Per Share | -0.00 | 0.61 | 1.65 | 2.58 | 3.95 |
Machinery | 1.11 | 1.35 | 1.24 | 0.99 | 0.73 |
Construction In Progress | 0.74 | 0.56 | 0.52 | 0.07 | - |